Our advertisers

Baxter Healthcare Ltd
vCreate Neonatal
Medela AG
CliniMed Limited
University of Plymouth
Milton Pharmaceuticals Co UK Ltd
Intersurgical Ltd
Central Medical Supplies Ltd
Vygon (UK) Ltd
ParAid
Inspiration Healthcare
Nutricia Ltd
Solus Medical Limited
Armstrong Medical
The Brazelton Centre UK

 

 

Volume 14/Issue 6, November 2018

Surfactant therapy – past, present and future

Patrick M. McCrossan, David G. Sweet


Surfactant replacement therapy for newborn infants with respiratory distress syndrome (RDS) has been available for about 35 years. During this time practice has evolved in relation to type of surfactant, timing and mode of administration. This review looks briefly at the history of surfactant use and how this has changed to shape current practice. We also speculate on potential future innovations that may further refine how this life-saving therapy is used.

McCrossan P.M., Sweet D.G. Surfactant therapy – past, present and futureInfant 2018;14(6): 218-22.
Abbreviated: Please subscribe and log in to see the full article.

 
© Copyright of Stansted News Limited 2019. Terms & Conditions of reading. Privacy policy